LEADER 01495nas  2200517-a 450 
001 996335457603316
005 20210116032049.6
011   $a1758-4329
035   $a(OCoLC)406983210
035   $a(CKB)1000000000579887
035   $a(CONSER)--2009243648
035   $a(MiFhGG)3GMF
035   $a(MiAaPQ)105522
035   $a(EXLCZ)991000000000579887
100   $a20090604b20092010  ---            -
101 0 $aeng
181   $ctxt$2rdacontent
182   $cn$2rdamedia
200 00$aHIV therapy
210   $aLondon, UK $cFuture Medicine
300   $aRefereed/Peer-reviewed
311   $a1758-4310 
517 1 $aHIV ther
531   $aHIV THER
606   $aAIDS (Disease)$xTreatment$vPeriodicals
606   $aHIV infections$vPeriodicals
606   $aAIDS vaccines$vPeriodicals
606   $aAIDS (Disease)$xTreatment$2fast$3(OCoLC)fst00793971
606   $aAIDS vaccines$2fast$3(OCoLC)fst00794025
606   $aHIV infections$2fast$3(OCoLC)fst00949871
606   $aHIV Infections
606   $aHIV Infections$xtherapy
608   $aPeriodicals.$2fast
608   $aPeriodicals.
615  0$aAIDS (Disease)$xTreatment
615  0$aHIV infections
615  0$aAIDS vaccines
615  7$aAIDS (Disease)$xTreatment.
615  7$aAIDS vaccines.
615  7$aHIV infections.
615 12$aHIV Infections.
615 22$aHIV Infections$xtherapy.
906   $aJOURNAL
912   $a996335457603316
996   $aHIV therapy$92384223
997   $aUNISA